Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067340 · ClinicalTrials.gov registry record · Phase 3
Caries Transmission Prevention in Alaska Native Infants
A Phase 3 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT00067340 is a Phase 3 study that was terminated before completion, run by University of Washington. The registered enrollment target is 250 participants.
The verdict
NCT00067340, a Phase 3 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a community based, randomized control trial to determine if the use of chlorhexidine mouth rinse and xylitol-sweetened chewing gum will reduce the vertical transmission of caries between Alaska Native mothers to their infants.
Interventions
- DRUG Chlorhexidine mouth rinse
- OTHER Xylitol chewing gum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2003-04 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067340
The ClinicalTrials.gov registry entry for NCT00067340 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine mouth rinse is the first listed.
NCT00067340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067340 about?
NCT00067340 is a clinical study titled "Caries Transmission Prevention in Alaska Native Infants". The purpose of this study is to conduct a community based, randomized control trial to determine if the use of chlorhexidine mouth rinse and xylitol-sweetened chewing gum will reduce the vertical transmission of caries between Alaska Native mothers to their infants.
What is the current status of trial NCT00067340?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2003-04. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00067340?
The interventions under investigation include: Chlorhexidine mouth rinse (DRUG), Xylitol chewing gum (OTHER).
Who is sponsoring clinical trial NCT00067340?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.